Safety and efficacy of humanized CD19-targeted CAR-T cells in patients with relapsed/refractory acute B cell lymphoblastic leukemia

This study aimed to evaluate the safety and efficacy of humanized CD19-targeted chimeric antigen receptor T-cell (CAR-T) in patients with relapsed/refractory acute B cell lymphoblastic leukemia (R/R B-ALL) . The clinical data of 41 patients with R/R B-ALL treated with humanized CD19-targeted CAR-T c...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Zhōnghuá xuèyèxué zázhì 2022-08, Vol.43 (8), p.651
Hauptverfasser:	Song, F M, Hu, Y X, Zhang, M M, Wu, W W, Xu, H J, Zhang, H S, Huang, H, Wei, G Q
Format:	Artikel
Sprache:	chi
Schlagworte:	Antigens, CD19 Hematopoietic Stem Cell Transplantation Humans Immunotherapy, Adoptive - adverse effects Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy Receptors, Chimeric Antigen - therapeutic use T-Lymphocytes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!